PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-32.17%
Both yoy net incomes decline, with MRVL at -39.69%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
277.57%
Some D&A expansion while MRVL is negative at -0.14%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-600.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
66.96%
SBC growth well above MRVL's 4.86%. Michael Burry would flag major dilution risk vs. competitor’s approach.
171.31%
Well above MRVL's 15.39% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
117.67%
AR growth while MRVL is negative at -162.67%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
135.76%
Some inventory rise while MRVL is negative at -100.09%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-111.27%
Negative yoy AP while MRVL is 1033.48%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
653.33%
Growth well above MRVL's 199.88%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-325.00%
Negative yoy while MRVL is 321.11%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
72.39%
Operating cash flow growth above 1.5x MRVL's 28.58%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-40.00%
Negative yoy CapEx while MRVL is 47.16%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-20891.18%
Negative yoy acquisition while MRVL stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-756.52%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
128900.00%
Liquidation growth of 128900.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-608.55%
Both yoy lines negative, with MRVL at -94.89%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-1178.67%
We reduce yoy invests while MRVL stands at 46.34%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
99.84%
Debt repayment growth of 99.84% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
100.00%
We have some buyback growth while MRVL is negative at -0.04%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.